Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
77,760,476
-
Share change
-
+3,181,242
-
Total reported value
-
$52,789,242
-
Put/Call ratio
-
4%
-
Price per share
-
$0.65
-
Number of holders
-
117
-
Value change
-
+$1,721,467
-
Number of buys
-
42
-
Number of sells
-
54
Institutional Holders of ZIOPHARM ONCOLOGY INC - COM (TCRT) as of Q4 2022
As of 31 Dec 2022,
ZIOPHARM ONCOLOGY INC - COM (TCRT) was held by
117 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,760,476 shares.
The largest 10 holders included
DISCOVERY CAPITAL MANAGEMENT, LLC / CT, MSD Partners, L.P., VANGUARD GROUP INC, Laurion Capital Management LP, BlackRock Inc., GREEN SQUARE CAPITAL ADVISORS LLC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, and TWO SIGMA INVESTMENTS, LP.
This page lists
117
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.